Evaluation of immune responses to influenza vaccination in chronic obstructive pulmonary disease

Journal of Vaccines and Vaccination

Volumn 4, Issue 6, 2013, Pages

  Burel, Julie G ^a   Nath, Karthik ^a   Pritchard, Antonia L ^a   White, Olivia J ^a   Davies, Janet M ^a   Towers, Michelle ^b   Looke, David ^a,b   Upham, John W ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Chronic Obstructive Pulmonary Disease (COPD); Influenza virus; Innate and adaptive immune response; Vaccination

Indexed keywords

EID: 84884732745     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.S4-001     Document Type: Article

References (47)

1. World Health Organization (2004) Programmes and projects-Chronic Obstructive Pulmonary Disease.
2. Varkey JB, Varkey AB, Varkey B (2009) Prophylactic vaccinations in chronic obstructive pulmonary disease: current status. Curr Opin Pulm Med 15: 90-99.
3. McManus TE, Marley AM, Baxter N, Christie SN, O'Neill HJ, et al. (2008) Respiratory viral infection in exacerbations of COPD. Respir Med 102: 1575-1580.
4. Varkey JB, Varkey B (2008) Viral infections in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 14: 89-94.
5. Vozoris NT, Lougheed MD (2009) Influenza vaccination among Canadians with chronic respiratory disease. Respir Med 103: 50-58.
6. Pesek R, Lockey R (2011) Vaccination of adults with asthma and COPD. Allergy 66: 25-31.
7. Global Strategy for the Diagnosis (2011) Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
8. Australian and New Zealand guidelines for the management of Chronic Obstructive Pulmonary disease (2011)
9. Nichol KL, Baken L, Nelson A (1999) Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130: 397-403.
10. Vila-Corcoles A, Ochoa O, de DC, Valdivieso A, Herreros I, et al. (2008) Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease. Int J Clin Pract 62: 10-17.
11. Eurich DT, Marrie TJ, Johnstone J, Majumdar SR (2008) Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? Am J Respir Crit Care Med 178: 527-533.
12. Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, et al. (2006) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35: 345-352.
13. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
14. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35: 337-344.
15. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ (2006) Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev: CD002733.
16. Howells CH, Tyler LE (1961) Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial. Lancet 2: 1428-1432.
17. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, et al. (2004) Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125: 2011-2020.
18. Woodland DL, Hogan RJ, Zhong W (2001) Cellular immunity and memory to respiratory virus infections. Immunol Res 24: 53-67.
19. Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus AD (2004) Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 103: 125-132.
20. Halliley JL, Kyu S, Kobie JJ, Walsh EE, Falsey AR, et al. (2010) Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 28: 3582-3587.
21. Lee FE, Halliley JL, Walsh EE, Moscatiello AP, Kmush BL, et al. (2011) Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol 186: 5514-5521.
22. Brown DM, Roman E, Swain SL (2004) CD4 T cell responses to influenza infection. Semin Immunol 16: 171-177.
23. He XS, Mahmood K, Maecker HT, Holmes TH, Kemble GW, et al. (2003) Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis 187: 1075-1084.
24. Kreijtz JH, Fouchier RA, Rimmelzwaan GF (2011) Immune responses to influenza virus infection. Virus Res 162: 19-30.
25. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, et al. (2001) Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12: 171-180.
26. Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
27. Rodrigues L, Bonorino C (2009) Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies. Expert Rev Vaccines 8: 167-177.
28. Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, et al. (2009) The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med 206: 69-78.
29. Avery DT, Bryant VL, Ma CS, de WMR, Tangye SG (2008) IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J Immunol 181: 1767-1779.
30. Pallikkuth S, Pilakka KS, Silva SY, Fischl M, Pahwa R, et al. (2011) Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. J Immunol 186: 6173-6181.
31. Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, et al. (2010) Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J 35: 64-71.
32. Quah BJ, Warren HS, Parish CR (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2: 2049-2056.
33. Schandene L, Del Prete GF, Cogan E, Stordeur P, Crusiaux A, et al. (1996) Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 97: 309-315.
34. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.
35. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
36. Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, et al. (2011) Influenza vaccine immunology. Immunol Rev 239: 167-177.
37. Schneider D, Ganesan S, Comstock AT, Meldrum CA, Mahidhara R, et al. (2010) Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 332-340.
38. Costa CH, Rufino R, Lapa ESJR (2009) [Inflammatory cells and their mediators in COPD pathogenesis]. Rev Assoc Med Bras 55: 347-354.
39. Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, et al. (2010) IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 207: 365-378.
40. Avery DT, Ellyard JI, Mackay F, Corcoran LM, Hodgkin PD, et al. (2005) Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol 174: 4034-4042.
41. Bedognetti D, Zoppoli G, Massucco C, Zanardi E, Zupo S, et al. (2011) Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximabcontaining regimens. J Immunol186: 6044-6055.
42. Toapanta FR, Ross TM (2009) Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res10: 112.
43. Mbawuike I, Zang Y, Couch RB (2007) Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant. Vaccine 25: 3263-3269.
44. Gorse GJ, O'Connor TZ, Young SL, Mendelman PM, Bradley SF, et al. (2003) Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 21: 2133-2144.
45. Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, et al. (2011) Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol 127: 130-137, 137. e1-3.
46. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ (2009) Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of highdose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 200: 172-180.
47. Baldo V, Baldovin T, Floreani A, Carraro AM, Trivello R (2007) MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 25: 3955-3961.